Quick Answer
Adicet Bio, Inc. reported Common Stock Shares Outstanding of 9.59 million shares for the year ending 2025.
- Adicet Bio, Inc. showed an increase of +85.8% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Adicet Bio, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: 28.05 million shares | Q2 2018: 28.05 million shares | Q3 2018: 28.05 million shares | Q1 2019: 35.26 million shares | Q2 2019: 35.82 million shares | Q3 2019: 36.44 million shares | Q1 2020: 36.44 million shares | Q2 2020: 36.44 million shares | Q3 2020: 19.59 million shares | Q4 2020: 39.74 million shares | Q1 2021: 31.80 million shares | Q2 2021: 31.84 million shares | Q3 2021: 39.89 million shares | Q2 2022: 40.02 million shares | Q3 2022: 42.79 million shares | Q1 2023: 42.96 million shares | Q2 2023: 43.07 million shares | Q3 2023: 43.11 million shares | Q1 2024: 82.17 million shares | Q2 2024: 82.40 million shares | Q3 2024: 82.40 million shares | Q1 2025: 82.71 million shares | Q2 2025: 83.25 million shares | Q3 2025: 83.25 million shares.
- Over the full 9 years of available data (2017 to 2025), Adicet Bio, Inc.'s Common Stock Shares Outstanding has grown by 69.4%.
- Historical annual values: Fiscal year 2025: 9.59 million shares | Fiscal year 2024: 5.16 million shares | Fiscal year 2023: 43.27 million shares | Fiscal year 2022: 42.95 million shares | Fiscal year 2021: 39.74 million shares | Fiscal year 2020: 19.68 million shares | Fiscal year 2019: 2.16 million shares | Fiscal year 2018: 28.06 million shares | Fiscal year 2017: 5.66 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: